Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment recommendations in Primary Ciliary Dyskinesia.
Polineni D, Davis SD, Dell SD. Polineni D, et al. Paediatr Respir Rev. 2016 Mar;18:39-45. doi: 10.1016/j.prrv.2015.10.002. Epub 2015 Oct 20. Paediatr Respir Rev. 2016. PMID: 26586601 Review.
Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline.
Shapiro AJ, Davis SD, Polineni D, Manion M, Rosenfeld M, Dell SD, Chilvers MA, Ferkol TW, Zariwala MA, Sagel SD, Josephson M, Morgan L, Yilmaz O, Olivier KN, Milla C, Pittman JE, Daniels MLA, Jones MH, Janahi IA, Ware SM, Daniel SJ, Cooper ML, Nogee LM, Anton B, Eastvold T, Ehrne L, Guadagno E, Knowles MR, Leigh MW, Lavergne V; American Thoracic Society Assembly on Pediatrics. Shapiro AJ, et al. Among authors: polineni d. Am J Respir Crit Care Med. 2018 Jun 15;197(12):e24-e39. doi: 10.1164/rccm.201805-0819ST. Am J Respir Crit Care Med. 2018. PMID: 29905515 Free PMC article.
Race, Gender, and Faculty Retention in Academic Medicine.
Scheuermann TS, Clark L, Sultana N, Machado N, Shergina E, Polineni D, Shih GH, Simari RD, Wick JA, Richter KP. Scheuermann TS, et al. Among authors: polineni d. JAMA Netw Open. 2024 Nov 4;7(11):e2445143. doi: 10.1001/jamanetworkopen.2024.45143. JAMA Netw Open. 2024. PMID: 39541115 Free PMC article.
Efficacy and safety of LAU-7b in a Phase 2 trial in adults with cystic fibrosis.
Konstan MW, Polineni D, Chmiel JF, Bilodeau L, Middleton PG, Matouk E, Houle JM, Pislariu R, Colin P, Kianicka I, Potvin D, Radzioch D, Kotsimbos T, Zuckerman JB, Nasr SZ, Liou TG, Lands LC; study Investigators. Konstan MW, et al. Among authors: polineni d. J Cyst Fibros. 2024 Jul 9:S1569-1993(24)00789-6. doi: 10.1016/j.jcf.2024.07.004. Online ahead of print. J Cyst Fibros. 2024. PMID: 38987119
Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study.
Daines CL, Tullis E, Costa S, Linnemann RW, Mall MA, McKone EF, Polineni D, Quon BS, Ringshausen FC, Rowe SM, Selvadurai H, Taylor-Cousar JL, Withers NJ, Ahluwalia N, Moskowitz SM, Prieto-Centurion V, Tan YV, Tian S, Weinstock T, Xuan F, Zhang Y, Ramsey B, Griese M; VX17-445-105 Study Group. Daines CL, et al. Among authors: polineni d. Eur Respir J. 2023 Dec 7;62(6):2202029. doi: 10.1183/13993003.02029-2022. Print 2023 Dec. Eur Respir J. 2023. PMID: 37945033 Free PMC article. Clinical Trial.
39 results